Global Live Cell Encapsulation Market

Live Cell Encapsulation Comprehensive Study by Type (Alginate, HEMA-MMA (Hydroxyethyl Methacrylate-methyl Methacrylate), Siliceous Encapsulates, Cellulose Sulfate, PAN-PVC (Acrylonitrile Vinyl Chloride), Others), Application (Probiotics, Transplant, Drug Delivery, Research), Manufacturing Technique (Simple Dripping, Electrostatic Dripping, Coaxial Airflow, Rotating Disk Atomization, Others) Players and Region - Global Market Outlook to 2027

Live Cell Encapsulation Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 3.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Cell encapsulation is the primary machinery for cell based therapeutic delivery system. Live cell encapsulation technology is used for immobilization of cells within the semipermeable membrane. The technique provides significant advantages as compared to protein encapsulation. The encapsulation of cells is used to allow the delivery of molecules of interest for a longer time as cells used to release these molecules of interest continuously. Further, ongoing technological advancements in live cell encapsulation and increasing public awareness about the clinical role of encapsulated cells in disease management is driving the global live cell encapsulation market.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledBioTime, Inc. (United States), Reed Pacific Pty Ltd. (Australia), Viacyte, Inc. (United States), Neurotech Pharmaceuticals, Inc. (United States), Living Cell Technologies Ltd. (Australia), Merck KGAA (Germany), Sigilon Therapeutics, Inc. (United States), Encapsys, LLC (United States), Evonik Industries (Germany), Lycored (Israel) and MiKroCaps (Slovenia)
CAGR3.2%


According to AMA, the market for Live Cell Encapsulation is expected to register a CAGR of 3.2% during the forecast period to 2027. This growth is primarily driven by Increasing Number of Target Patient Population, Growing Public & Private Investments in the field of Live Cell Encapsulation and Rising Clinical Data for the Efficacy of Cell Encapsulation Techniques.

Globally, a noticeable market trend is evident Increasing Adoption of Novel Drug Delivery System for the Treatment of Acute & Chronic Disease. The Life Sciences Tools & Services sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as BioTime, Inc. (United States), Reed Pacific Pty Ltd. (Australia), Viacyte, Inc. (United States), Neurotech Pharmaceuticals, Inc. (United States), Living Cell Technologies Ltd. (Australia), Merck KGAA (Germany), Sigilon Therapeutics, Inc. (United States), Encapsys, LLC (United States), Evonik Industries (Germany), Lycored (Israel) and MiKroCaps (Slovenia) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
January 2019, PharmaCyte Biotech, Inc. a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box PharmaCyte’s partner, Austrianova, has successfully encapsulated the live cells used in PharmaCyte’s therapy for its planned clinical trial in patients with locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC). The cells are now growing and dividing inside the Cell-in-a-Box capsules.
In August 2018, Balchem Italia S.r.l., a wholly owned subsidiary of Balchem Corporation, acquired Bioscreen Technologies, S.r.l., a privately held manufacturer of encapsulated and fermented feed nutrition ingredients. With this, the company aims to expand its position in the market.

Market Drivers
  • Increasing Number of Target Patient Population
  • Growing Public & Private Investments in the field of Live Cell Encapsulation
  • Rising Clinical Data for the Efficacy of Cell Encapsulation Techniques

Market Trend
  • Increasing Adoption of Novel Drug Delivery System for the Treatment of Acute & Chronic Disease

Restraints
  • Limited Availability of High Quality Raw Materials
  • Lack of Skilled Professionals, Ethical & Legal Issues

Opportunities
Increasing Investments for the Development of Novel Therapeutics
Challenges
Significant Adoption of Alternative Therapies is posing a Challenge for the Market

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Live Cell Encapsulation Study Sheds Light on
— The Live Cell Encapsulation Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Live Cell Encapsulation industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Live Cell Encapsulation industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Alginate
  • HEMA-MMA [Hydroxyethyl Methacrylate-methyl Methacrylate]
  • Siliceous Encapsulates
  • Cellulose Sulfate
  • PAN-PVC [Acrylonitrile Vinyl Chloride]
  • Others
By Application
  • Probiotics
  • Transplant
  • Drug Delivery
  • Research
By Manufacturing Technique
  • Simple Dripping
  • Electrostatic Dripping
  • Coaxial Airflow
  • Rotating Disk Atomization
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Target Patient Population
      • 3.2.2. Growing Public & Private Investments in the field of Live Cell Encapsulation
      • 3.2.3. Rising Clinical Data for the Efficacy of Cell Encapsulation Techniques
    • 3.3. Market Challenges
      • 3.3.1. Significant Adoption of Alternative Therapies is posing a Challenge for the Market
    • 3.4. Market Trends
      • 3.4.1. Increasing Adoption of Novel Drug Delivery System for the Treatment of Acute & Chronic Disease
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Live Cell Encapsulation, by Type, Application, Manufacturing Technique and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Live Cell Encapsulation (Value)
      • 5.2.1. Global Live Cell Encapsulation by: Type (Value)
        • 5.2.1.1. Alginate
        • 5.2.1.2. HEMA-MMA [Hydroxyethyl Methacrylate-methyl Methacrylate]
        • 5.2.1.3. Siliceous Encapsulates
        • 5.2.1.4. Cellulose Sulfate
        • 5.2.1.5. PAN-PVC [Acrylonitrile Vinyl Chloride]
        • 5.2.1.6. Others
      • 5.2.2. Global Live Cell Encapsulation by: Application (Value)
        • 5.2.2.1. Probiotics
        • 5.2.2.2. Transplant
        • 5.2.2.3. Drug Delivery
        • 5.2.2.4. Research
      • 5.2.3. Global Live Cell Encapsulation by: Manufacturing Technique (Value)
        • 5.2.3.1. Simple Dripping
        • 5.2.3.2. Electrostatic Dripping
        • 5.2.3.3. Coaxial Airflow
        • 5.2.3.4. Rotating Disk Atomization
        • 5.2.3.5. Others
      • 5.2.4. Global Live Cell Encapsulation Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Live Cell Encapsulation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioTime, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Reed Pacific Pty Ltd. (Australia)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Viacyte, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Neurotech Pharmaceuticals, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Living Cell Technologies Ltd. (Australia)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck KGAA (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sigilon Therapeutics, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Encapsys, LLC (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Evonik Industries (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Lycored (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. MiKroCaps (Slovenia)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Live Cell Encapsulation Sale, by Type, Application, Manufacturing Technique and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Live Cell Encapsulation (Value)
      • 7.2.1. Global Live Cell Encapsulation by: Type (Value)
        • 7.2.1.1. Alginate
        • 7.2.1.2. HEMA-MMA [Hydroxyethyl Methacrylate-methyl Methacrylate]
        • 7.2.1.3. Siliceous Encapsulates
        • 7.2.1.4. Cellulose Sulfate
        • 7.2.1.5. PAN-PVC [Acrylonitrile Vinyl Chloride]
        • 7.2.1.6. Others
      • 7.2.2. Global Live Cell Encapsulation by: Application (Value)
        • 7.2.2.1. Probiotics
        • 7.2.2.2. Transplant
        • 7.2.2.3. Drug Delivery
        • 7.2.2.4. Research
      • 7.2.3. Global Live Cell Encapsulation by: Manufacturing Technique (Value)
        • 7.2.3.1. Simple Dripping
        • 7.2.3.2. Electrostatic Dripping
        • 7.2.3.3. Coaxial Airflow
        • 7.2.3.4. Rotating Disk Atomization
        • 7.2.3.5. Others
      • 7.2.4. Global Live Cell Encapsulation Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Live Cell Encapsulation: by Type(USD Million)
  • Table 2. Live Cell Encapsulation Alginate , by Region USD Million (2016-2021)
  • Table 3. Live Cell Encapsulation HEMA-MMA [Hydroxyethyl Methacrylate-methyl Methacrylate] , by Region USD Million (2016-2021)
  • Table 4. Live Cell Encapsulation Siliceous Encapsulates , by Region USD Million (2016-2021)
  • Table 5. Live Cell Encapsulation Cellulose Sulfate , by Region USD Million (2016-2021)
  • Table 6. Live Cell Encapsulation PAN-PVC [Acrylonitrile Vinyl Chloride] , by Region USD Million (2016-2021)
  • Table 7. Live Cell Encapsulation Others , by Region USD Million (2016-2021)
  • Table 8. Live Cell Encapsulation: by Application(USD Million)
  • Table 9. Live Cell Encapsulation Probiotics , by Region USD Million (2016-2021)
  • Table 10. Live Cell Encapsulation Transplant , by Region USD Million (2016-2021)
  • Table 11. Live Cell Encapsulation Drug Delivery , by Region USD Million (2016-2021)
  • Table 12. Live Cell Encapsulation Research , by Region USD Million (2016-2021)
  • Table 13. Live Cell Encapsulation: by Manufacturing Technique(USD Million)
  • Table 14. Live Cell Encapsulation Simple Dripping , by Region USD Million (2016-2021)
  • Table 15. Live Cell Encapsulation Electrostatic Dripping , by Region USD Million (2016-2021)
  • Table 16. Live Cell Encapsulation Coaxial Airflow , by Region USD Million (2016-2021)
  • Table 17. Live Cell Encapsulation Rotating Disk Atomization , by Region USD Million (2016-2021)
  • Table 18. Live Cell Encapsulation Others , by Region USD Million (2016-2021)
  • Table 19. South America Live Cell Encapsulation, by Country USD Million (2016-2021)
  • Table 20. South America Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 21. South America Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 22. South America Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 23. Brazil Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 24. Brazil Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 25. Brazil Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 26. Argentina Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 27. Argentina Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 28. Argentina Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 29. Rest of South America Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 30. Rest of South America Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 31. Rest of South America Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 32. Asia Pacific Live Cell Encapsulation, by Country USD Million (2016-2021)
  • Table 33. Asia Pacific Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 34. Asia Pacific Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 35. Asia Pacific Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 36. China Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 37. China Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 38. China Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 39. Japan Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 40. Japan Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 41. Japan Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 42. India Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 43. India Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 44. India Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 45. South Korea Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 46. South Korea Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 47. South Korea Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 48. Taiwan Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 49. Taiwan Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 50. Taiwan Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 51. Australia Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 52. Australia Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 53. Australia Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 55. Rest of Asia-Pacific Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 56. Rest of Asia-Pacific Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 57. Europe Live Cell Encapsulation, by Country USD Million (2016-2021)
  • Table 58. Europe Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 59. Europe Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 60. Europe Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 61. Germany Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 62. Germany Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 63. Germany Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 64. France Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 65. France Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 66. France Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 67. Italy Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 68. Italy Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 69. Italy Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 70. United Kingdom Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 71. United Kingdom Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 72. United Kingdom Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 73. Netherlands Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 74. Netherlands Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 75. Netherlands Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 76. Rest of Europe Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 77. Rest of Europe Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 78. Rest of Europe Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 79. MEA Live Cell Encapsulation, by Country USD Million (2016-2021)
  • Table 80. MEA Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 81. MEA Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 82. MEA Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 83. Middle East Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 84. Middle East Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 85. Middle East Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 86. Africa Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 87. Africa Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 88. Africa Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 89. North America Live Cell Encapsulation, by Country USD Million (2016-2021)
  • Table 90. North America Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 91. North America Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 92. North America Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 93. United States Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 94. United States Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 95. United States Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 96. Canada Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 97. Canada Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 98. Canada Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 99. Mexico Live Cell Encapsulation, by Type USD Million (2016-2021)
  • Table 100. Mexico Live Cell Encapsulation, by Application USD Million (2016-2021)
  • Table 101. Mexico Live Cell Encapsulation, by Manufacturing Technique USD Million (2016-2021)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Live Cell Encapsulation: by Type(USD Million)
  • Table 114. Live Cell Encapsulation Alginate , by Region USD Million (2022-2027)
  • Table 115. Live Cell Encapsulation HEMA-MMA [Hydroxyethyl Methacrylate-methyl Methacrylate] , by Region USD Million (2022-2027)
  • Table 116. Live Cell Encapsulation Siliceous Encapsulates , by Region USD Million (2022-2027)
  • Table 117. Live Cell Encapsulation Cellulose Sulfate , by Region USD Million (2022-2027)
  • Table 118. Live Cell Encapsulation PAN-PVC [Acrylonitrile Vinyl Chloride] , by Region USD Million (2022-2027)
  • Table 119. Live Cell Encapsulation Others , by Region USD Million (2022-2027)
  • Table 120. Live Cell Encapsulation: by Application(USD Million)
  • Table 121. Live Cell Encapsulation Probiotics , by Region USD Million (2022-2027)
  • Table 122. Live Cell Encapsulation Transplant , by Region USD Million (2022-2027)
  • Table 123. Live Cell Encapsulation Drug Delivery , by Region USD Million (2022-2027)
  • Table 124. Live Cell Encapsulation Research , by Region USD Million (2022-2027)
  • Table 125. Live Cell Encapsulation: by Manufacturing Technique(USD Million)
  • Table 126. Live Cell Encapsulation Simple Dripping , by Region USD Million (2022-2027)
  • Table 127. Live Cell Encapsulation Electrostatic Dripping , by Region USD Million (2022-2027)
  • Table 128. Live Cell Encapsulation Coaxial Airflow , by Region USD Million (2022-2027)
  • Table 129. Live Cell Encapsulation Rotating Disk Atomization , by Region USD Million (2022-2027)
  • Table 130. Live Cell Encapsulation Others , by Region USD Million (2022-2027)
  • Table 131. South America Live Cell Encapsulation, by Country USD Million (2022-2027)
  • Table 132. South America Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 133. South America Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 134. South America Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 135. Brazil Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 136. Brazil Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 137. Brazil Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 138. Argentina Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 139. Argentina Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 140. Argentina Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 141. Rest of South America Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 142. Rest of South America Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 143. Rest of South America Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 144. Asia Pacific Live Cell Encapsulation, by Country USD Million (2022-2027)
  • Table 145. Asia Pacific Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 146. Asia Pacific Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 147. Asia Pacific Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 148. China Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 149. China Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 150. China Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 151. Japan Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 152. Japan Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 153. Japan Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 154. India Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 155. India Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 156. India Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 157. South Korea Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 158. South Korea Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 159. South Korea Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 160. Taiwan Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 161. Taiwan Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 162. Taiwan Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 163. Australia Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 164. Australia Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 165. Australia Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 166. Rest of Asia-Pacific Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 167. Rest of Asia-Pacific Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 168. Rest of Asia-Pacific Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 169. Europe Live Cell Encapsulation, by Country USD Million (2022-2027)
  • Table 170. Europe Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 171. Europe Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 172. Europe Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 173. Germany Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 174. Germany Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 175. Germany Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 176. France Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 177. France Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 178. France Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 179. Italy Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 180. Italy Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 181. Italy Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 182. United Kingdom Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 183. United Kingdom Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 184. United Kingdom Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 185. Netherlands Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 186. Netherlands Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 187. Netherlands Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 188. Rest of Europe Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 189. Rest of Europe Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 190. Rest of Europe Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 191. MEA Live Cell Encapsulation, by Country USD Million (2022-2027)
  • Table 192. MEA Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 193. MEA Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 194. MEA Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 195. Middle East Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 196. Middle East Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 197. Middle East Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 198. Africa Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 199. Africa Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 200. Africa Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 201. North America Live Cell Encapsulation, by Country USD Million (2022-2027)
  • Table 202. North America Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 203. North America Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 204. North America Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 205. United States Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 206. United States Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 207. United States Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 208. Canada Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 209. Canada Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 210. Canada Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 211. Mexico Live Cell Encapsulation, by Type USD Million (2022-2027)
  • Table 212. Mexico Live Cell Encapsulation, by Application USD Million (2022-2027)
  • Table 213. Mexico Live Cell Encapsulation, by Manufacturing Technique USD Million (2022-2027)
  • Table 214. Research Programs/Design for This Report
  • Table 215. Key Data Information from Secondary Sources
  • Table 216. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Live Cell Encapsulation: by Type USD Million (2016-2021)
  • Figure 5. Global Live Cell Encapsulation: by Application USD Million (2016-2021)
  • Figure 6. Global Live Cell Encapsulation: by Manufacturing Technique USD Million (2016-2021)
  • Figure 7. South America Live Cell Encapsulation Share (%), by Country
  • Figure 8. Asia Pacific Live Cell Encapsulation Share (%), by Country
  • Figure 9. Europe Live Cell Encapsulation Share (%), by Country
  • Figure 10. MEA Live Cell Encapsulation Share (%), by Country
  • Figure 11. North America Live Cell Encapsulation Share (%), by Country
  • Figure 12. Global Live Cell Encapsulation share by Players 2021 (%)
  • Figure 13. Global Live Cell Encapsulation share by Players (Top 3) 2021(%)
  • Figure 14. Global Live Cell Encapsulation share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. BioTime, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. BioTime, Inc. (United States) Revenue: by Geography 2021
  • Figure 18. Reed Pacific Pty Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 19. Reed Pacific Pty Ltd. (Australia) Revenue: by Geography 2021
  • Figure 20. Viacyte, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Viacyte, Inc. (United States) Revenue: by Geography 2021
  • Figure 22. Neurotech Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Neurotech Pharmaceuticals, Inc. (United States) Revenue: by Geography 2021
  • Figure 24. Living Cell Technologies Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 25. Living Cell Technologies Ltd. (Australia) Revenue: by Geography 2021
  • Figure 26. Merck KGAA (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Merck KGAA (Germany) Revenue: by Geography 2021
  • Figure 28. Sigilon Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Sigilon Therapeutics, Inc. (United States) Revenue: by Geography 2021
  • Figure 30. Encapsys, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 31. Encapsys, LLC (United States) Revenue: by Geography 2021
  • Figure 32. Evonik Industries (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Evonik Industries (Germany) Revenue: by Geography 2021
  • Figure 34. Lycored (Israel) Revenue, Net Income and Gross profit
  • Figure 35. Lycored (Israel) Revenue: by Geography 2021
  • Figure 36. MiKroCaps (Slovenia) Revenue, Net Income and Gross profit
  • Figure 37. MiKroCaps (Slovenia) Revenue: by Geography 2021
  • Figure 38. Global Live Cell Encapsulation: by Type USD Million (2022-2027)
  • Figure 39. Global Live Cell Encapsulation: by Application USD Million (2022-2027)
  • Figure 40. Global Live Cell Encapsulation: by Manufacturing Technique USD Million (2022-2027)
  • Figure 41. South America Live Cell Encapsulation Share (%), by Country
  • Figure 42. Asia Pacific Live Cell Encapsulation Share (%), by Country
  • Figure 43. Europe Live Cell Encapsulation Share (%), by Country
  • Figure 44. MEA Live Cell Encapsulation Share (%), by Country
  • Figure 45. North America Live Cell Encapsulation Share (%), by Country
List of companies from research coverage that are profiled in the study
  • BioTime, Inc. (United States)
  • Reed Pacific Pty Ltd. (Australia)
  • Viacyte, Inc. (United States)
  • Neurotech Pharmaceuticals, Inc. (United States)
  • Living Cell Technologies Ltd. (Australia)
  • Merck KGAA (Germany)
  • Sigilon Therapeutics, Inc. (United States)
  • Encapsys, LLC (United States)
  • Evonik Industries (Germany)
  • Lycored (Israel)
  • MiKroCaps (Slovenia)
Additional players considered in the study are as follows:
PharmaCyte Biotech, Inc. (United States) , BCHI Labortechnik AG (Germany) , Blacktrace Holdings Ltd (UK) , Sernova Corporation (Canada) , Balchem Corporation (United States)
Select User Access Type

Key Highlights of Report


May 2022 167 Pages 56 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Live Cell Encapsulation Market Quantitative research analysis
Global Live Cell Encapsulation Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Live Cell Encapsulation market is expected to see a CAGR of 3.2% during projected year 2021 to 2027.
Top performing companies in the Global Live Cell Encapsulation market are BioTime, Inc. (United States), Reed Pacific Pty Ltd. (Australia), Viacyte, Inc. (United States), Neurotech Pharmaceuticals, Inc. (United States), Living Cell Technologies Ltd. (Australia), Merck KGAA (Germany), Sigilon Therapeutics, Inc. (United States), Encapsys, LLC (United States), Evonik Industries (Germany), Lycored (Israel) and MiKroCaps (Slovenia), to name a few.
North America is dominating the Live Cell Encapsulation Market.

Know More About Global Live Cell Encapsulation Market Report?

Have a Query? Click Here

Other Related Reports

DNA 3D Printing Comprehensive Study by Type (3D Printer, Laser Technology, DNA Sample, Enzyme), Application (Bioengineering / R&D, Pharmaceutical Drugs/ Therapies, Agriculture Industry, Energy, Other...
$ 3650
HCS Software and Services Comprehensive Study by Type (HCS Services, HCS Software), Application (Compound Profiling, Primary and Secondary Screening, Automated Microscopy and Image Analysis, Target I...
$ 3750
Aerospace and Life Science TIC Comprehensive Study by Type (Testing Services, Inspection Services, Certification Services, Others), Application (Aerospace, Medical & Life Sciences), Sourcing (In-hous...
$ 3500
Life Science & Analytical Instruments Comprehensive Study by Application (Clinical Analysis., Forensic Analysis., Chemical, Food & Beverage Analysis., Pharmaceutical Analysis., Life science research,...
$ 3800
Chiral Chromatography Comprehensive Study by Type (Pre-Packed Columns, Empty Columns), Application (Pharmaceuticals, Agrochemicals, Flavors/Fragrances), Technology (Biological Separation, Asymmetric ...
$ 3500
Liquid Analysis Test Kit Comprehensive Study by Type (Physical, Chemical, Biological), Application (Institutional, Research and development agencies, Commercial, Beverage and Food Processing, Industr...
$ 3450